E.A. Tsochatzis, J. Bosch, A.K. Burroughs, Liver cirrhosis, The Lancet 383 (2014) 1749–1761. https://doi.org/10.1016/S0140-6736(14)60121-5.

Article  Google Scholar 

N. Mesropyan, A. Isaak, A. Faron, M. Praktiknjo, C. Jansen, D. Kuetting, C. Meyer, C.C. Pieper, A.M. Sprinkart, J. Chang, B. Maedler, D. Thomas, P. Kupczyk, U. Attenberger, J.A. Luetkens, Magnetic resonance parametric mapping of the spleen for non-invasive assessment of portal hypertension, Eur Radiol 31 (2021) 85–93. https://doi.org/10.1007/s00330-020-07080-5.

Article  CAS  PubMed  Google Scholar 

P. Ginès, A. Krag, J.G. Abraldes, E. Solà, N. Fabrellas, P.S. Kamath, Liver cirrhosis, The Lancet 398 (2021) 1359–1376. https://doi.org/10.1016/S0140-6736(21)01374-X.

Article  Google Scholar 

X. Qi, A. Berzigotti, A. Cardenas, S.K. Sarin, Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension, The Lancet Gastroenterology & Hepatology 3 (2018) 708–719. https://doi.org/10.1016/S2468-1253(18)30232-2.

Article  Google Scholar 

A. Forner, M. Reig, J. Bruix, Hepatocellular carcinoma, The Lancet 391 (2018) 1301–1314. https://doi.org/10.1016/S0140-6736(18)30010-2.

Article  Google Scholar 

S.K. Asrani, H. Devarbhavi, J. Eaton, P.S. Kamath, Burden of liver diseases in the world, Journal of Hepatology 70 (2019) 151–171. https://doi.org/10.1016/j.jhep.2018.09.014.

Article  PubMed  Google Scholar 

Global burden of liver disease: 2023 update - Journal of Hepatology, (n.d.). https://www.journal-of-hepatology.eu/article/S0168-8278(23)00194-0/fulltext (accessed August 6, 2024).

N. Goossens, S. Bellentani, A. Cerny, J.-F. Dufour, F.R. Jornayvaz, J. Mertens, A. Moriggia, B. Muellhaupt, F. Negro, H. Razavi, D. Semela, C. Estes, Nonalcoholic fatty liver disease burden – Switzerland 2018–2030, Swiss Medical Weekly 149 (2019). https://doi.org/10.4414/smw.2019.20152.

G. Marchesini, R. Vettor, M. Pinzani, MASLD emerging from the fog of fatty liver, Journal of Hepatology 80 (2024) 178–180. https://doi.org/10.1016/j.jhep.2023.10.011.

Article  CAS  PubMed  Google Scholar 

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention | Nature Reviews Gastroenterology & Hepatology, (n.d.). https://www.nature.com/articles/nrgastro.2017.109 (accessed August 6, 2024).

K. Ozaki, O. Matsui, S. Kobayashi, T. Minami, A. Kitao, T. Gabata, Morphometric changes in liver cirrhosis: aetiological differences correlated with progression, BJR 89 (2016) 20150896. https://doi.org/10.1259/bjr.20150896.

Article  PubMed  PubMed Central  Google Scholar 

S.K. Venkatesh, M.S. Torbenson, Liver fibrosis quantification, Abdom Radiol 47 (2022) 1032–1052. https://doi.org/10.1007/s00261-021-03396-y.

Article  Google Scholar 

W.P. Harbin, N.J. Robert, J.T. Ferrucci, Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis., Radiology 135 (1980) 273–283. https://doi.org/10.1148/radiology.135.2.7367613.

Article  CAS  PubMed  Google Scholar 

H. Awaya, D.G. Mitchell, T. Kamishima, G. Holland, K. Ito, T. Matsumoto, Cirrhosis: Modified Caudate–Right Lobe Ratio, Radiology 224 (2002) 769–774. https://doi.org/10.1148/radiol.2243011495.

Article  PubMed  Google Scholar 

V.C. Obmann, N. Mertineit, A. Berzigotti, C. Marx, L. Ebner, R. Kreis, P. Vermathen, J.T. Heverhagen, A. Christe, A.T. Huber, CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans, PLOS ONE 13 (2018) e0199611. https://doi.org/10.1371/journal.pone.0199611.

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Zbinden, D. Catucci, Y. Suter, L. Hulbert, A. Berzigotti, M. Brönnimann, L. Ebner, A. Christe, V.C. Obmann, R. Sznitman, A.T. Huber, Automated liver segmental volume ratio quantification on non-contrast T1–Vibe Dixon liver MRI using deep learning, European Journal of Radiology 167 (2023). https://doi.org/10.1016/j.ejrad.2023.111047.

Article  PubMed  Google Scholar 

B.E. Van Beers, I. Leconte, R. Materne, A.M. Smith, J. Jamart, Y. Horsmans, Hepatic Perfusion Parameters in Chronic Liver Disease, American Journal of Roentgenology 176 (2001) 667–673. https://doi.org/10.2214/ajr.176.3.1760667.

Article  PubMed  Google Scholar 

V.C. Obmann, C. Marx, J. Hrycyk, A. Berzigotti, L. Ebner, N. Mertineit, Ch. Gräni, J.T. Heverhagen, A. Christe, A.T. Huber, Liver segmental volume and attenuation ratio (LSVAR) on portal venous CT scans improves the detection of clinically significant liver fibrosis compared to liver segmental volume ratio (LSVR), Abdom Radiol 46 (2021) 1912–1921. https://doi.org/10.1007/s00261-020-02834-7.

Article  CAS  Google Scholar 

D. Sharpe, Chi-Square Test is Statistically Significant: Now What?, Practical Assessment, Research, and Evaluation 20 (2019). https://doi.org/10.7275/tbfa-x148.

A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research, Journal of Chiropractic Medicine 15 (2016) 155–163. https://doi.org/10.1016/j.jcm.2016.02.012.

O.M. Furusato Hunt, M.G. Lubner, T.J. Ziemlewicz, A. Muñoz del Rio, P.J. Pickhardt, The Liver Segmental Volume Ratio for Noninvasive Detection of Cirrhosis: Comparison With Established Linear and Volumetric Measures, Journal of Computer Assisted Tomography 40 (2016) 478. https://doi.org/10.1097/RCT.0000000000000389.

P.J. Pickhardt, K. Malecki, O.F. Hunt, C. Beaumont, J. Kloke, T.J. Ziemlewicz, M.G. Lubner, Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis, Eur Radiol 27 (2017) 3060–3068. https://doi.org/10.1007/s00330-016-4648-0.

Article  PubMed  Google Scholar 

M. Romero-Cristóbal, A. Clemente-Sánchez, E. Ramón, L. Téllez, E. Canales, O. Ortega-Lobete, E. Velilla-Aparicio, M.-V. Catalina, L. Ibáñez-Samaniego, S. Alonso, A. Colón, A.-M. Matilla, M. Salcedo, A. Albillos, R. Bañares, D. Rincón, CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma, JHEPReport 5 (2023). https://doi.org/10.1016/j.jhepr.2022.100645.

T.-H. Kim, J.E. Kim, J.-H. Ryu, C.-W. Jeong, Development of liver surface nodularity quantification program and its clinical application in nonalcoholic fatty liver disease, Sci Rep 9 (2019) 9994. https://doi.org/10.1038/s41598-019-46442-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

P.J. Pickhardt, K. Malecki, J. Kloke, M.G. Lubner, Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis, American Journal of Roentgenology 207 (2016) 1194–1199. https://doi.org/10.2214/AJR.16.16514.

Article  PubMed  Google Scholar 

M.G. Lubner, D. Jones, A. Said, J. Kloke, S. Lee, P.J. Pickhardt, Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus, Abdom Radiol 43 (2018) 2980–2986. https://doi.org/10.1007/s00261-018-1572-6.

Article  Google Scholar 

A.D. Smith, C.R. Branch, K. Zand, C. Subramony, H. Zhang, K. Thaggard, R. Hosch, J. Bryan, A. Vasanji, M. Griswold, X. Zhang, Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis, Radiology 280 (2016) 771–781. https://doi.org/10.1148/radiol.2016151542.

Article  PubMed  Google Scholar 

A.A. Elkassem, B.C. Allen, S.T. Lirette, K.L. Cox, E.M. Remer, P.J. Pickhardt, M.G. Lubner, C.B. Sirlin, T. Dondlinger, M. Schmainda, R.B. Jacobus, P.E. Severino, A.D. Smith, Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients With Hepatitis C, AJR Am J Roentgenol 218 (2022) 833–845. https://doi.org/10.2214/AJR.21.27062.

Article  PubMed  Google Scholar 

R. Sartoris, P.-E. Rautou, L. Elkrief, G. Pollorsi, F. Durand, D. Valla, L. Spahr, S. Terraz, O. Soubrane, F. Cauchy, V. Vilgrain, M. Ronot, Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension, Radiology 289 (2018) 698–707. https://doi.org/10.1148/radiol.2018181131.

Article  PubMed  Google Scholar 

V.C. Obmann, D. Catucci, A. Berzigotti, C. Gräni, L. Ebner, J.T. Heverhagen, A. Christe, A.T. Huber, T1 reduction rate with Gd-EOB-DTPA determines liver function on both 1.5 T and 3 T MRI, Scientific Reports 12 (2022) 4716. https://doi.org/10.1038/s41598-022-08659-2.

D. Catucci, V.C. Obmann, A. Berzigotti, C. Gräni, D.P. Guensch, K. Fischer, L. Ebner, J.T. Heverhagen, A. Christe, A.T. Huber, Noninvasive assessment of clinically significant portal hypertension using ΔT1 of the liver and spleen and ECV of the spleen on routine Gd-EOB-DTPA liver MRI, European Journal of Radiology 144 (2021). https://doi.org/10.1016/j.ejrad.2021.109958.